Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions to supply up to 300 million doses of an experimental COVID19 vaccine for the 27country European Union.
from Top Business News- News18.com https://ift.tt/39NwHdm
via IFTTT
Subscribe to:
Post Comments (Atom)
Beyond Borders: The True Origins Of India's Favorite Brands - Colgate, Bata And Maruti
Bata grew into one of the world's leading shoemakers, with an impressive annual sale of 150 million pairs of shoes across more than 70 c...
-
Theyve endured a financial crisis. Two deep recessions. Mounds of student debt. Stagnant pay. Costly health care. Dim job prospects. from ...
-
Krsnaa Diagnostics IPO Allotment: Investors can check the share allotment status in two ways a) via BSE b) via registrar’s website from To...
-
....क्योंकि पढ़ाई के लिए महंगी कीमत चुकानी पड़ती है... यहां के बच्चों को बाघों के इलाके में पढ़ने लिए हर... from आज तक https://ift.tt/2Ec...
No comments:
Post a Comment